Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: SilverFox77 who wrote (69409)	4/16/1999 12:48:00 PM
From: Mr. Big	Read Replies (2) \| Respond to of 119973

Vivus Inc. (NASDAQ:VVUS - news) shares rose more than 26%, or $1.19 to $5.69 before ebbing to $5.38, after the company said it would crush earnings expectations for the first quarter, due primarily to a one-time payment of $4 million from Swedish drug maker Astra AB. The company, which makes an injectible impotency treatment, said its earnings for the quarter would be approximately three times higher than the $0.04 per share forecast by PaineWebber's Charles Olsziewski, the sole analyst polled by First Call. Vivus has had a tough time competing with Pfizer's Viagra, and as such has remained a money losing company. Its CEO, Leland Wilson, does not expect the Astra payment to affect the company's full-year results. --------------------------------------------------------------------------------